139 related articles for article (PubMed ID: 15546136)
1. Interdependence of N-acetyl aspartate and high-energy phosphates in healthy human brain.
Pan JW; Takahashi K
Ann Neurol; 2005 Jan; 57(1):92-7. PubMed ID: 15546136
[TBL] [Abstract][Full Text] [Related]
2. Quantitative magnetic resonance spectroscopy of schizophrenia: relationship between decreased N-acetylaspartate and frontal lobe dysfunction.
Tanaka Y; Obata T; Sassa T; Yoshitome E; Asai Y; Ikehira H; Suhara T; Okubo Y; Nishikawa T
Psychiatry Clin Neurosci; 2006 Jun; 60(3):365-72. PubMed ID: 16732755
[TBL] [Abstract][Full Text] [Related]
3. The effect of antidepressant treatment on N-acetyl aspartate levels of medial frontal cortex in drug-free depressed patients.
Gonul AS; Kitis O; Ozan E; Akdeniz F; Eker C; Eker OD; Vahip S
Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jan; 30(1):120-5. PubMed ID: 16236417
[TBL] [Abstract][Full Text] [Related]
4. In vivo evidence for cerebral depletion in high-energy phosphates in progressive supranuclear palsy.
Stamelou M; Pilatus U; Reuss A; Magerkurth J; Eggert KM; Knake S; Ruberg M; Schade-Brittinger C; Oertel WH; Höglinger GU
J Cereb Blood Flow Metab; 2009 Apr; 29(4):861-70. PubMed ID: 19190655
[TBL] [Abstract][Full Text] [Related]
5. Hippocampal 1H MRS in first-episode bipolar I patients.
Atmaca M; Yildirim H; Ozdemir H; Poyraz AK; Tezcan E; Ogur E
Prog Neuropsychopharmacol Biol Psychiatry; 2006 Sep; 30(7):1235-9. PubMed ID: 16725248
[TBL] [Abstract][Full Text] [Related]
6. Spectroscopic evidence of cerebral axonopathy in patients with "pure" adrenomyeloneuropathy.
Dubey P; Fatemi A; Barker PB; Degaonkar M; Troeger M; Zackowski K; Bastian A; Smith SA; Pomper MG; Moser HW; Raymond GV
Neurology; 2005 Jan; 64(2):304-10. PubMed ID: 15668429
[TBL] [Abstract][Full Text] [Related]
7. Met carriers of BDNF Val66Met genotype show increased N-acetylaspartate concentration in the anterior cingulate cortex.
Gallinat J; Schubert F; Brühl R; Hellweg R; Klär AA; Kehrer C; Wirth C; Sander T; Lang UE
Neuroimage; 2010 Jan; 49(1):767-71. PubMed ID: 19683059
[TBL] [Abstract][Full Text] [Related]
8. Hippocampal metabolic abnormalities in mild cognitive impairment and Alzheimer's disease.
Ackl N; Ising M; Schreiber YA; Atiya M; Sonntag A; Auer DP
Neurosci Lett; 2005 Aug 12-19; 384(1-2):23-8. PubMed ID: 15905028
[TBL] [Abstract][Full Text] [Related]
9. Proton magnetic resonance spectroscopy of normal human brain and glioma: a quantitative in vivo study.
Tong ZY; Toshiaki Y; Wang YJ
Chin Med J (Engl); 2005 Aug; 118(15):1251-7. PubMed ID: 16117877
[TBL] [Abstract][Full Text] [Related]
10. N-acetylaspartate to total creatine ratio in the hippocampal CA1 sector after transient cerebral ischemia in gerbils: influence of neuronal elements, reactive gliosis, and tissue atrophy.
Konaka K; Ueda H; Li JY; Matsumoto M; Sakoda S; Yanagihara T
J Cereb Blood Flow Metab; 2003 Jun; 23(6):700-8. PubMed ID: 12796718
[TBL] [Abstract][Full Text] [Related]
11. Cognitive impairment and in vivo metabolites in first-episode neuroleptic-naive and chronic medicated schizophrenic patients: a proton magnetic resonance spectroscopy study.
Ohrmann P; Siegmund A; Suslow T; Pedersen A; Spitzberg K; Kersting A; Rothermundt M; Arolt V; Heindel W; Pfleiderer B
J Psychiatr Res; 2007 Oct; 41(8):625-34. PubMed ID: 16949099
[TBL] [Abstract][Full Text] [Related]
12. Hippocampal dysfunction in Gulf War Syndrome. A proton MR spectroscopy study.
Menon PM; Nasrallah HA; Reeves RR; Ali JA
Brain Res; 2004 May; 1009(1-2):189-94. PubMed ID: 15120596
[TBL] [Abstract][Full Text] [Related]
13. Metabolic changes in the normal ageing brain: consistent findings from short and long echo time proton spectroscopy.
Gruber S; Pinker K; Riederer F; Chmelík M; Stadlbauer A; Bittsanský M; Mlynárik V; Frey R; Serles W; Bodamer O; Moser E
Eur J Radiol; 2008 Nov; 68(2):320-7. PubMed ID: 17964104
[TBL] [Abstract][Full Text] [Related]
14. Neurochemistry of the hippocampus in patients with obsessive-compulsive disorder.
Atmaca M; Yildirim H; Ozdemir H; Koc M; Ozler S; Tezcan E
Psychiatry Clin Neurosci; 2009 Aug; 63(4):486-90. PubMed ID: 19531109
[TBL] [Abstract][Full Text] [Related]
15. Cerebral creatine kinase deficiency influences metabolite levels and morphology in the mouse brain: a quantitative in vivo 1H and 31P magnetic resonance study.
in 't Zandt HJ; Renema WK; Streijger F; Jost C; Klomp DW; Oerlemans F; Van der Zee CE; Wieringa B; Heerschap A
J Neurochem; 2004 Sep; 90(6):1321-30. PubMed ID: 15341516
[TBL] [Abstract][Full Text] [Related]
16. In vivo proton magnetic resonance spectroscopy of the temporal lobe in Alzheimer's disease.
Frederick BD; Lyoo IK; Satlin A; Ahn KH; Kim MJ; Yurgelun-Todd DA; Cohen BM; Renshaw PF
Prog Neuropsychopharmacol Biol Psychiatry; 2004 Dec; 28(8):1313-22. PubMed ID: 15588758
[TBL] [Abstract][Full Text] [Related]
17. Regional metabolic changes in the hippocampus and posterior cingulate area detected with 3-Tesla magnetic resonance spectroscopy in patients with mild cognitive impairment and Alzheimer disease.
Wang Z; Zhao C; Yu L; Zhou W; Li K
Acta Radiol; 2009 Apr; 50(3):312-9. PubMed ID: 19235582
[TBL] [Abstract][Full Text] [Related]
18. Magnetic resonance spectroscopy reveals an epileptic network in juvenile myoclonic epilepsy.
Lin K; Carrete H; Lin J; Peruchi MM; de Araújo Filho GM; Guaranha MS; Guilhoto LM; Sakamoto AC; Yacubian EM
Epilepsia; 2009 May; 50(5):1191-200. PubMed ID: 19220412
[TBL] [Abstract][Full Text] [Related]
19. MRI volumetry and proton MR spectroscopy of the brain in Lafora disease.
Villanueva V; Alvarez-Linera J; Gómez-Garre P; Gutiérrez J; Serratosa JM
Epilepsia; 2006 Apr; 47(4):788-92. PubMed ID: 16650146
[TBL] [Abstract][Full Text] [Related]
20. Temporal lobe magnetic resonance spectroscopic imaging following selective amygdalohippocampectomy for treatment-resistant epilepsy.
Spencer DC; Szumowski J; Kraemer DF; Wang PY; Burchiel KJ; Spielman DM
Acta Neurol Scand; 2005 Jul; 112(1):6-12. PubMed ID: 15932349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
